ProPhase Labs Inc (NASDAQ:PRPH)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting -0.41. At the close of trading, the stock’s price was $0.26, to imply an increase of 0.27% or $0.0 in intraday trading. The PRPH share’s 52-week high remains $7.48, putting it -2776.92% down since that peak but still an impressive 15.38% since price per share fell to its 52-week low of $0.22. The company has a valuation of $7.78M, with an average of 2.12 million shares in intraday trading volume over the past 10 days and average of 641.62K shares over the past 3 months.
Analysts have given a consensus recommendation of Hold for ProPhase Labs Inc (PRPH), translating to a mean rating of 1.00. Of 1 analyst(s) looking at the stock, 0 analyst(s) give PRPH a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 0 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.24.
ProPhase Labs Inc (NASDAQ:PRPH) trade information
After registering a 0.27% upside in the last session, ProPhase Labs Inc (PRPH) has traded red over the past five days. The 5-day price performance for the stock is -1.03%, and -63.56% over 30 days. With these gigs, the year-to-date price performance is -65.58%. Short interest in ProPhase Labs Inc (NASDAQ:PRPH) saw shorts transact 0.15 million shares and set a 7.04 days time to cover.
The extremes give us $14 and $14 for target low and target high price respectively. As such, PRPH has been trading -5284.62% off suggested target high and -5284.62% from its likely low.
ProPhase Labs Inc (PRPH) estimates and forecasts
The rating firms project that company’s revenue will shrink -67.29% compared to the previous financial year.
Revenue forecast for the current quarter as set by 1 analysts is 5.88M. Meanwhile, for the current quarter, a total of 1 analyst(s) estimate revenue growth to 5.64M.Earnings reports from the last fiscal year show that sales brought in 4.35M and 3.63M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 35.14% before jumping 55.20% in the following quarter.
PRPH Dividends
ProPhase Labs Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
ProPhase Labs Inc (NASDAQ:PRPH)’s Major holders
ProPhase Labs Inc insiders hold 14.34% of total outstanding shares, with institutional holders owning 7.63% of the shares at 8.91% float percentage. In total, 7.63% institutions holds shares in the company, led by VANGUARD GROUP INC. As of 2024-06-30, the company held over 0.66 million shares (or 3.6351% of shares), all amounting to roughly $2.74 million.
The next major institution holding the largest number of shares is RENAISSANCE TECHNOLOGIES LLC with 0.22 million shares, or about 1.222% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $0.92 million.
We also have Vanguard Total Stock Market Index Fund and Perritt Microcap Opportunities Fund as the top two Mutual Funds with the largest holdings of the ProPhase Labs Inc (PRPH) shares. Going by data provided on Sep 30, 2024 , Vanguard Total Stock Market Index Fund holds roughly 454.64 shares. This is just over 1.90% of the total shares, with a market valuation of $0.12 million. Data from the same date shows that the other fund manager holds a little less at 190.0, or 0.80% of the shares, all valued at about 49514.0.
